GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,960 | -11.8% | 18,000 | 0.0% | 0.00% | – |
| Q2 2023 | $35,100 | -79.8% | 18,000 | -57.3% | 0.00% | – |
| Q1 2022 | $174,000 | -67.8% | 42,200 | +0.2% | 0.00% | – |
| Q4 2021 | $541,000 | +52.0% | 42,100 | +27.6% | 0.00% | – |
| Q3 2021 | $356,000 | +18.3% | 33,000 | 0.0% | 0.00% | – |
| Q2 2021 | $301,000 | +30.9% | 33,000 | +35.2% | 0.00% | – |
| Q1 2021 | $230,000 | +42.9% | 24,400 | -40.2% | 0.00% | – |
| Q4 2020 | $161,000 | +49.1% | 40,800 | 0.0% | 0.00% | – |
| Q3 2020 | $108,000 | -63.6% | 40,800 | -8.9% | 0.00% | – |
| Q2 2020 | $297,000 | +92.9% | 44,800 | +69.7% | 0.00% | – |
| Q1 2020 | $154,000 | -7.8% | 26,400 | +41.9% | 0.00% | – |
| Q4 2019 | $167,000 | +3.7% | 18,600 | 0.0% | 0.00% | – |
| Q3 2019 | $161,000 | +10.3% | 18,600 | +42.0% | 0.00% | – |
| Q2 2019 | $146,000 | -48.8% | 13,100 | -34.5% | 0.00% | – |
| Q3 2018 | $285,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |